Pharmageek

Le projet ZooCov, déployé durant un an et demi au Cambodge, avance ses principaux résultats, fondements de la mise en place d’une surveillance intégrée des maladies émergentes. Lancé au début de la pandémie de Covid-19 sur un financement de l’ANR, il constitue un exemple concret des bénéfices de l’approche One Health, indispensable pour prévenir l’émergence de nouvelles maladies et de potentielles futures pandémies. Facteurs clés de ses réussites : une collaboration internationale multidisciplinaire de dix-sept partenaires et le soutien des ministères cambodgiens de l’Agriculture, de l’Environnement et de la Santé.

Lire l'article complet sur : www.cirad.fr

Since March 2020, all global health-care institutions have been threatened by the

spread of COVID-19 among the population. Emergency departments were confronted with

many patients with suspected SARS-CoV-2 infection and the subsequent risk of contaminating

other patients and health-care providers. In already fragile or overburdened health-care

systems, no hospital was fully prepared to manage such a rapidly spreading disease.

A substantial challenge resided in finding the appropriate method to distinguish patients

with a potential SARS-CoV-2 infection from others to contain in-hospital contamination,

considering the limited availability of appropriate laboratory screening tests, poor

sensitivity, high costs, and consequent delays in obtaining adequate results.

Lire l'article complet sur : www.thelancet.com

The COVID-19 pandemic has led health systems to increase the use of tools for monitoring

and triaging patients remotely. In this systematic review, we aim to assess the effectiveness

and safety of pulse oximetry in remote patient monitoring (RPM) of patients at home

with COVID-19. We searched five databases (MEDLINE, Embase, Global Health, medRxiv,

and bioRxiv) from database inception to April 15, 2021, and included feasibility studies,

clinical trials, and observational studies, including preprints.

Lire l'article complet sur : www.thelancet.com

Bonne nouvelle, notre espérance de vie augmente, et ce, dans de bonnes conditions. Entre 1991 et 2011, les hommes ont gagné en moyenne 3,7 ans d’espérance de vie en bonne santé, autrement dit, sans maladie handicapante. 

Lire l'article complet sur : www.santemagazine.fr